Polyhedra Group appoints Steve Hobbs
pharmafile | April 1, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | polyhedra group, steve hobbs
Steve Hobbs has been appointed chief business development officer for The Polyhedra Group.
Hobbs has over 30 years’ international experience in pharmaceuticals and healthcare, and has recently been involved in patient-centric specialising in order to improve health outcomes, market access and product use.
Prior to joining the firm Hobbs was among Apodi’s senior management team as director of business and account development, and previously worked for Australian corporate advisory firm Achieve Capital.
Prior to working at Achieve Capital Hobbs had a successful marketing, sales and business development career in the pharma industry working at Boehringer Mannheim, Servier Laboratories and Innovex UK – and then launching Innovex in Australia.
The Polyhedra Group produce secure codes for pharmaceutical packs which Patients and healthcare professionals can scan with a smartphone to access information and download apps.






